{
  "zip": "32792",
  "sector": "Healthcare",
  "longBusinessSummary": "Immune Therapeutics, Inc., a late development-stage biopharmaceutical company, focuses on the development, commercialization, and licensing of prescription medications for humans, animals, and pets worldwide. It develops low dose naltrexone and methionine encephalin therapies for human immunodeficiency virus (HIV) infections, autoimmune diseases, immune disorders, or cancer. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in December 2014. Immune Therapeutics, Inc. is headquartered in Orlando, Florida.",
  "city": "Winter Park",
  "phone": "888 613 8802",
  "state": "FL",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.immunetherapeutics.com",
  "maxAge": 1,
  "address1": "2431 Aloma Avenue",
  "industry": "Biotechnology",
  "address2": "Suite 124",
  "previousClose": 0.0164,
  "regularMarketOpen": 0.0179,
  "twoHundredDayAverage": 0.01941446,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0179,
  "navPrice": null,
  "averageDailyVolume10Day": 948294,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.0164,
  "fiftyDayAverage": 0.016001819,
  "trailingAnnualDividendRate": null,
  "open": 0.0179,
  "averageVolume10days": 948294,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.067226,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0157,
  "priceHint": 4,
  "currency": "USD",
  "trailingPE": 5.633333,
  "regularMarketVolume": 2380791,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 7849543,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 3991015,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.0157,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 2380791,
  "fiftyTwoWeekHigh": 0.0499,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0052,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.0179,
  "exchange": "PNK",
  "shortName": "IMMUNE THERAPEUTICS INC FLA",
  "longName": "Immune Therapeutics, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "IMUN",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_206968409",
  "uuid": "65e7bbf8-38ea-368d-964f-a28301b01e45",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -5.552,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 464470016,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.024,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.07643,
  "netIncomeToCommon": 1576945,
  "trailingEps": 0.003,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.0727,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 464437487,
  "enterpriseValue": 10478047,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1330300800,
  "lastSplitFactor": "1:1000",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0179,
  "logo_url": "https://logo.clearbit.com/immunetherapeutics.com"
}